BIO Middle East 2026 is a leading biotechnology and life sciences conference designed to accelerate innovation, investment, and collaboration across the Middle East. Hosted in Riyadh, the event brings together biotech executives, pharmaceutical leaders, research institutions, regulators, and investors to explore emerging trends in drug development, precision medicine, advanced therapeutics, and biomanufacturing. The conference aligns with the region’s growing focus on healthcare transformation and life sciences sector development.

Key Highlights

• High-level discussions on biotechnology innovation, drug development, and life sciences commercialization.

• Dedicated focus on investment opportunities and venture capital activity within the regional biotech ecosystem.

• Participation from government health authorities, regulators, and research institutions.

• Strategic networking sessions connecting biotech companies with global investors and partners.

Who Should Attend?

• Biotechnology and pharmaceutical company executives.

• Venture capital firms and private equity investors focused on life sciences.

• Government health regulators and policymakers.

• Research institutions and academic leaders in biomedical sciences.

• Biotech startups and innovation-driven founders.

• Healthcare industry consultants and strategic advisors.

Main Event Features

• Conference Sessions – Expert panels discussing advanced therapeutics, precision medicine, biomanufacturing, and regulatory frameworks.

• Investment & Partnering Meetings – Curated sessions designed to connect biotech companies with investors and strategic partners.

• Innovation Showcases – Presentations highlighting emerging technologies and research breakthroughs in biotechnology.